Adaptive’s platform applies proprietary chemistry, computational biology, and machine learning to read the genetic code of a patient’s immune system. The platform takes the key cells of the adaptive immune system that enable the body to mount responses against antigens—T cells and B cells—extracts and sequences their genomic DNA, then identifies the receptor sequences that are contained within those cells . . .

Get GEN Edge Today!

See More on the Edge

Continue reading this article and more
with a GEN Edge subscription

Start Your 30-Day Free Trial Now

Log In Join GEN Edge